Arax Advisory Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.5K Buy
1,000
+906
+964% +$36.5K ﹤0.01% 3422
2026
Q1
$3.39K Buy
94
+91
+3,033% +$3.81K ﹤0.01% 2951
2025
Q4
$136 Sell
3
-1,263
-100% -$46.2K ﹤0.01% 3782
2025
Q3
$38.5K Buy
+1,266
New +$38.9K ﹤0.01% 1956
2024
Q4
Sell
-21
Closed -$916 2652
2024
Q3
$916 Hold
21
﹤0.01% 2286
2024
Q2
$569 Buy
+21
New +$608 ﹤0.01% 2313
2024
Q1
Sell
-33
Closed -$1.24K 1375
2023
Q4
$1.24K Buy
+33
New +$1.21K ﹤0.01% 1102

Other funds holding OMCL

Arax Advisory Partners's OMCL Position: Q2 2026 in Review

Arax Advisory Partners increased its Omnicell (OMCL) stake by 964% in Q2 2026, buying an estimated $36.5K and bringing the position to 1,000 shares worth $41.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3422.

Arax Advisory Partners first reported a position in OMCL in Q4 2023 and has held it in 7 quarters since. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Arax Advisory Partners held 1,000 shares of Omnicell worth $41.5K as of Q2 2026.
  • Arax Advisory Partners bought 906 Omnicell shares in Q2 2026, an estimated $36.5K.
  • Omnicell made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3422 holding.
  • Arax Advisory Partners first reported a position in Omnicell in Q4 2023 and has held it in 7 quarters since.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.